Many Alzheimer’s patients need to peaceful now not receive been eligible for clinical trials of controversial unusual drug

Credit rating: Unsplash/CC0 Public Domain In June 2021, the Food & Drug Administration (FDA) granted accelerated approval for aducanumab to address patients with relaxed cognitive…